It took eight months, but Connecticut lawmakers have added chronic pain as a qualifying condition to use medical cannabis, which could significantly boost the state’s growing, $100 million-plus market.
The new regulations will be submitted to the secretary of state’s office, which will post the regulations online. At that point, the regulations will be final.
Chronic pain, which Connecticut defines as pain that has lasted at least six months, generally is a leading sales driver for MMJ markets.
The state’s 8-year-old medical marijuana program has more than 40,000 registered patients.
The Marijuana Business Factbook estimated that MMJ sales in Connecticut reached $100 million-$120 million in 2019, up from $75 million-$90 million in 2018.